JP Morgan Chase
CPIX icon

JP Morgan Chase’s Cumberland Pharmaceuticals CPIX Stock Holding History

JP Morgan Chase’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19
Closed -$80 – 7163
2025
Q1 		$80 Hold
19
– – ﹤0.01% 6907
2024
Q4 		$45 Sell
19
-200
-91% -$295 ﹤0.01% 7153
2024
Q3 		$280 Buy
219
+199
+995% +$275 ﹤0.01% 6865
2024
Q2 		$31 Hold
20
– – ﹤0.01% 7108
2024
Q1 		$34 Buy
20
+8
+67% +$16 ﹤0.01% 7096
2023
Q4 		$21 Buy
12
+2
+20% +$4 ﹤0.01% 7334
2023
Q3 		$19 Buy
+10
New +$17 ﹤0.01% 7174
2020
Q4 		– Sell
-6
Closed – – 5666
2020
Q3 		$0 Hold
6
– – ﹤0.01% 5508
2020
Q2 		$0 Buy
+6
New +$22 ﹤0.01% 5411
2018
Q4 		– Sell
-3,868
Closed -$22K – 5712
2018
Q3 		$22K Buy
+3,868
New +$22.8K ﹤0.01% 5402
2018
Q1 		– Sell
-8,378
Closed -$62K – 5416
2017
Q4 		$62K Buy
+8,378
New +$61.7K ﹤0.01% 4822
2013
Q3 		– Sell
-18,455
Closed -$94K – 4384
2013
Q2 		$94K Buy
+18,455
New +$91.8K ﹤0.01% 4164

Other funds holding CPIX

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase's CPIX Position: Q2 2025 in Review

JP Morgan Chase sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2025, closing a stake of 19 shares — an estimated $80 sold.

JP Morgan Chase first reported a position in CPIX in Q2 2013 and held it in 12 quarters. The position peaked at $94K in Q2 2013. 31 funds tracked by Wall St. Rank hold CPIX as of Q2 2025.

  • JP Morgan Chase reported no remaining Cumberland Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 19 Cumberland Pharmaceuticals shares in Q2 2025, an estimated $80.
  • JP Morgan Chase first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • JP Morgan Chase's Cumberland Pharmaceuticals position peaked at $94K in Q2 2013.
  • 31 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.